Head-to-head comparison of 10 natriuretic peptide assays-Reference-Cited by-同舟云学术

Head-to-head comparison of 10 natriuretic peptide assays

Published:2015-01-01 Issue:11 Volume:53 Page:
ISSN:1437-4331
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:
Short-container-title:

Author:

Collin-Chavagnac Delphine,Dehoux Monique,Schellenberg François,Cauliez Bruno,Maupas-Schwalm Françoise,Lefevre Guillaume,on behalf of the Société Française

Abstract

AbstractThe aim of the study was to compare NT-proBNP and BNP levels in fresh samples from heart failure (HF) patients measured using 10 immunoassays and to assess their agreement.NT-proBNP (CobasH232The Pearson correlation coefficient ranged between 0.929 (TriageThis study stresses the lack of transferability of the results obtained using different techniques to measure BNP and NT-proBNP levels in fresh samples. Individual reference ranges and HF diagnostic cut-offs should be assessed for each commercial NP immunoassay. We recommend to systematically monitoring HF patients using the same assay (BNP or NT-proBNP) over the time.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2014-0592/pdf

Reference84 articles.

1. CM Biomarker - guided therapy in chronic heart failure : a meta - analysis of randomized controlled trials;Felker;Am Heart J,2009

2. committee for practice guidelines guidelines for the diagnosis and treatment of acute and chronic heart failure The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of;McMurray;Cardiology Eur Heart J,2012

3. Apple AS National Academy of Clinical and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines : analytical issues for biomarkers of heart failure;Wu;Biochemistry Clin Biochem,2008

4. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Developed in collaboration with the Heart Failure Association of;McMurray;Cardiology Eur J Heart Fail,2012

5. Long - term stability of endogenous type natriuretic peptide after storage at degrees or degrees;Pereira;Clin Chem Lab Med,2008

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a high-throughput liquid chromatography-tandem mass spectrometry platform for the determination of intact natriuretic peptides in human plasma;Talanta;2024-08

2. The multidimensional value of natriuretic peptides in heart failure, integrating laboratory and clinical aspects;Critical Reviews in Clinical Laboratory Sciences;2024-03-25

3. Cardiac natriuretic peptides;Advances in Clinical Chemistry;2024

4. An update on utilising brain natriuretic peptide for risk stratification, monitoring and guiding therapy in heart failure;Expert Review of Molecular Diagnostics;2023-05-27

5. Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment;Clinical Chemistry;2023-02-10